Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ventricular Systolic Function Study
NCT ID: NCT01535404
Last Updated: 2016-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
36 participants
INTERVENTIONAL
2012-01-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
LEft VEntricuLar Activation Time Shortening With Physiological Pacing vs Biventricular Resynchronization Therapy
NCT04054895
Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance
NCT01798043
Effect of Site of Right Ventricular (RV) Pacing on RV Function, Left Ventricular (LV) Dyssynchrony and Contraction Efficiency
NCT06636851
Left vs Left Randomized Clinical Trial
NCT05650658
Left Bundle Branch Area Pacing in Patients After TAVR
NCT05024279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Right ventricular apex pacing
Implantation procedure for a St-Jude Medical pacemaker system with right ventricular apex pacing
Implantation procedure for a St-Jude Medical pacemaker system with a transvenous ventricular and if applicable a right atrial lead
Left ventricular apex pacing
Implantation procedure for a St-Jude Medical pacemaker system with left ventricular apex pacing
Implantation procedure for a St-Jude Medical pacemaker system with a transvenous left ventricular (coronary sinus) and if applicable a right atrial lead
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implantation procedure for a St-Jude Medical pacemaker system with right ventricular apex pacing
Implantation procedure for a St-Jude Medical pacemaker system with a transvenous ventricular and if applicable a right atrial lead
Implantation procedure for a St-Jude Medical pacemaker system with left ventricular apex pacing
Implantation procedure for a St-Jude Medical pacemaker system with a transvenous left ventricular (coronary sinus) and if applicable a right atrial lead
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Anticipated \>=50% daily ventricular pacing
* LVEF \>=45% as evaluated by 2D-echocardiography, 3D-echocardiography, magnetic resonance imaging or by radionuclide/contrast ventriculography
* Minimum age of 18 years, and at least 1 year life expectancy
Exclusion Criteria
* Intrinsic rhythm \< 30bpm
* Patients with permanent atrial fibrillation who undergo ablation of the atrioventricular node.
* Echocardiographic window of insufficient quality for measuring LVEF
* Life expectancy of \< 1year
* Pregnancy (women of childbearing potential will undergo pregnancy testing)
* Unable of unwilling to sign a patient informed consent form
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Haran Burri, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haran Burri, MD
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haran Burri, Assoc. Prof.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Geneva
Angelo Auricchio, Prof.
Role: PRINCIPAL_INVESTIGATOR
Fondazione Cardiocentro Ticino (Lugano)
Christian Sticherling, Prof.
Role: STUDY_CHAIR
University Hospital of Basel
Paul Erne, Prof.
Role: STUDY_CHAIR
Luzerner Kantonsspital
Peter Ammann, PD Dr.
Role: STUDY_CHAIR
Cantonal Hospital of St. Gallen
Frits Prinzen, Dr.
Role: STUDY_CHAIR
Cardiovascular Research Institute, University of Maastricht
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiovascular Research Institute, University of Maastricht
Maastricht, , Netherlands
University Hospital of Basel
Basel, Canton of Basel-City, Switzerland
University Hospital Geneva
Geneva, Canton of Geneva, Switzerland
Kantonsspital Luzern
Lucerne, Canton of Lucerne, Switzerland
Kantonsspital St-Gallen
Sankt Gallen, Canton of St. Gallen, Switzerland
Cardiocentro Ticino (Lugano)
Lugano, Canton Ticino, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRM-CH-Riv01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.